For example, synthetic LXR agonists have been shown to inhibit IL-1β-induced production of Prostaglandin E2 (PGE2), as well as Cox-2 in osteoarthritic cartilage and in the synovial sarcoma cell line SW982 [31]. The gene discussed is IL1B; the disease is synovial sarcoma.